BioSpace News Archive

CVD Equipment Corporation, a leading provider of chemical vapor deposition systems, announced that it will release its 2021 first quarter results after markets close on Thursday May 13, 2021.

Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, reported its financial results for the first quarter ended March 31, 2021 and provided updated 2021 guidance.

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, reported financial results for the first quarter ended March 31, 2021 and provided a general business update.

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today reported financial results for the first quarter of 2021, and provided updates on its strong ophthalmology pipeline.

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, reported financial results for the first quarter ended April 2, 2021.

Cutera, Inc., a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, reported financial results for the first quarter ended March 31, 2021.

Q1 GAAP revenue including grant revenue $27.2M; Q1 non-GAAP revenue $24.9M, an increase of 58% versus prior year

Outset Medical, Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, reported financial results for the first quarter ended March 31, 2021.

DLH Holdings Corp., a leading provider of innovative healthcare services and solutions to federal agencies, announced financial results for its fiscal second quarter ended March 31, 2021.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, reported its financial results for the quarter ended March 31, 2021 and updated its sales guidance for the year ending December 31, 2021.